Filtros : "Boehringer Ingelheim" Removido: "Astellas" Limpar

Filtros



Refine with date range


  • Source: ATHEROSCLEROSIS PLUS. Unidade: FM

    Subjects: LIPOPROTEÍNAS LDL, INFARTO DO MIOCÁRDIO, FATORES DE RISCO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PONNAIAH, Maharajah et al. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations. ATHEROSCLEROSIS PLUS, v. 55, p. 21-30, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58815. Acesso em: 12 nov. 2024.
    • APA

      Ponnaiah, M., Zakiev, E., Lhomme, M., Rached, F., Camont, L., Serrano Junior, C. V., et al. (2024). Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations. ATHEROSCLEROSIS PLUS, 55, 21-30. doi:10.1016/j.athplu.2023.12.001
    • NLM

      Ponnaiah M, Zakiev E, Lhomme M, Rached F, Camont L, Serrano Junior CV, Santos Filho RD dos, Chapman MJ, Orekhov A, Kontush A. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations [Internet]. ATHEROSCLEROSIS PLUS. 2024 ; 55 21-30.[citado 2024 nov. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58815
    • Vancouver

      Ponnaiah M, Zakiev E, Lhomme M, Rached F, Camont L, Serrano Junior CV, Santos Filho RD dos, Chapman MJ, Orekhov A, Kontush A. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations [Internet]. ATHEROSCLEROSIS PLUS. 2024 ; 55 21-30.[citado 2024 nov. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58815
  • Source: Jacc-heart failure. Unidade: FM

    Subjects: INSUFICIÊNCIA CARDÍACA, SOBREVIDA, HIPERTENSÃO

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BOCCHI, Edimar Alcides e VENTURA, Hector O. Systemic blood pressure in heart failure the next frontier in prognosis and chronic HF treatment? [Editorial]. Jacc-heart failure. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.jchf.2022.02.017. Acesso em: 12 nov. 2024. , 2022
    • APA

      Bocchi, E. A., & Ventura, H. O. (2022). Systemic blood pressure in heart failure the next frontier in prognosis and chronic HF treatment? [Editorial]. Jacc-heart failure. Oxford: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.jchf.2022.02.017
    • NLM

      Bocchi EA, Ventura HO. Systemic blood pressure in heart failure the next frontier in prognosis and chronic HF treatment? [Editorial] [Internet]. Jacc-heart failure. 2022 ; 10( 6): 393-396.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.jchf.2022.02.017
    • Vancouver

      Bocchi EA, Ventura HO. Systemic blood pressure in heart failure the next frontier in prognosis and chronic HF treatment? [Editorial] [Internet]. Jacc-heart failure. 2022 ; 10( 6): 393-396.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.jchf.2022.02.017
  • Source: Circulation. Unidade: FM

    Subjects: INSUFICIÊNCIA CARDÍACA, HOMENS, MULHERES, PACIENTES INTERNADOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BUTLER, Javed et al. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction. Circulation, v. 146, n. 14, p. 1046-1055, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50467. Acesso em: 12 nov. 2024.
    • APA

      Butler, J., Filippatos, G., Siddiqi, T. J., Ferreira, J. P., Brueckmann, M., Bocchi, E. A., et al. (2022). Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction. Circulation, 146( 14), 1046-1055. doi:10.1161/CIRCULATIONAHA.122.059755
    • NLM

      Butler J, Filippatos G, Siddiqi TJ, Ferreira JP, Brueckmann M, Bocchi EA, Bohm M, Chopra VK, Giannetti N, Iwata T. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction [Internet]. Circulation. 2022 ; 146( 14): 1046-1055.[citado 2024 nov. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50467
    • Vancouver

      Butler J, Filippatos G, Siddiqi TJ, Ferreira JP, Brueckmann M, Bocchi EA, Bohm M, Chopra VK, Giannetti N, Iwata T. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction [Internet]. Circulation. 2022 ; 146( 14): 1046-1055.[citado 2024 nov. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50467
  • Source: Journal of the american college of cardiology. Unidade: FM

    Subjects: RESULTADO DE TRATAMENTO, INSUFICIÊNCIA CARDÍACA, FÁRMACOS SINTÉTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BOCCHI, Edimar Alcides e LIMA, Ivna Girard Cunha Vieira. The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy Quo Vadis?. Journal of the american college of cardiology, v. 80, n. 6, p. 595-597, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50443. Acesso em: 12 nov. 2024.
    • APA

      Bocchi, E. A., & Lima, I. G. C. V. (2022). The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy Quo Vadis? Journal of the american college of cardiology, 80( 6), 595-597. doi:10.1016/j.jacc.2022.05.028
    • NLM

      Bocchi EA, Lima IGCV. The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy Quo Vadis? [Internet]. Journal of the american college of cardiology. 2022 ; 80( 6): 595-597.[citado 2024 nov. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50443
    • Vancouver

      Bocchi EA, Lima IGCV. The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy Quo Vadis? [Internet]. Journal of the american college of cardiology. 2022 ; 80( 6): 595-597.[citado 2024 nov. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50443
  • Source: Indian journal of rheumatology. Unidade: FM

    Subjects: DOENÇAS AUTOIMUNES, COVID-19, VACINAS VIRAIS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SEN, Parikshit et al. Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study. Indian journal of rheumatology. Mumbai: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.4103/injr.injr_221_21. Acesso em: 12 nov. 2024. , 2022
    • APA

      Sen, P., Lilleker, J. B., Agarwal, V., Kardes, S., Milchert, M., Gheita, T., et al. (2022). Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study. Indian journal of rheumatology. Mumbai: Faculdade de Medicina, Universidade de São Paulo. doi:10.4103/injr.injr_221_21
    • NLM

      Sen P, Lilleker JB, Agarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Shinjo SK. Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study [Internet]. Indian journal of rheumatology. 2022 ; 17( 2): 188-191.[citado 2024 nov. 12 ] Available from: https://doi.org/10.4103/injr.injr_221_21
    • Vancouver

      Sen P, Lilleker JB, Agarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Shinjo SK. Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study [Internet]. Indian journal of rheumatology. 2022 ; 17( 2): 188-191.[citado 2024 nov. 12 ] Available from: https://doi.org/10.4103/injr.injr_221_21

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024